Search Orphan Drug Designations and Approvals
-
Generic Name: | R-4-amino-3-(4-chlorophenyl)butanoic acid |
---|---|
Date Designated: | 11/28/2008 |
Orphan Designation: | Treatment of the behavorial abnormalities associated with fragile X syndrome |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Clinical Research Associates, LLC 160 Fifth Avenue 7th Floor New York, New York 10010 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-